India, July 14 -- Hexaware Technologies and Abluva have entered a strategic partnership to bring secure and governed agentic AI solutions to the Life Sciences sector. As the industry embraces generative AI to transform drug development, clinical trials, and patient data operations, the need for robust governance frameworks has grown critical. This collaboration combines Hexaware's clinical domain expertise with Abluva's Secure Intelligence Plane, a framework designed to ensure AI agents operate safely, compliantly, and autonomously without exposing organisations to security or privacy risks.

Abluva's platform enables real-time governance of autonomous AI agents, enforcing strict controls like purpose binding, context-sensitive data handl...